Adjuvant chemoradiotherapy (CRT) plus pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC) with high risk of recurrence after neoadjuvant CRT plus surgery: A single-arm phase II study.

Journal

Journal of Clinical Oncology

Series/Report No.

Journal of Clinical Oncology

Journal Volume

42

Start Page

320

End Page

320

Date Issued

2024-01-20

Author(s)

Guo J.C.

Lin, Chia-Chi

Huang, Yen-Lin

Hsieh, Min-Shu

Huang, Pei-Ming

Lee, Jang-Ming

Wu, Shu-Ling

URI

Type

review article